Funding for this research was provided by:
National Cancer Institute (P50 CA244433)
Received: 2 February 2023
Accepted: 24 August 2023
First Online: 1 September 2023
: The Harvard Longwood Campus IRB approved the study procedures (Protocol IRB20-1232), with the Dana Farber and Mass General Brigham IRBs ceding review using the SMART IRB. Verbal consent was documented for all participants.
: Not applicable.
: The authors declare that they have no competing interests to declare. GK has a family financial interest in a digital health IT company, Dimagi, Inc.